-- Jeffrey A Meckler, Director, on May 04, 2026, sold 8,000 shares in Travere Therapeutics (TVTX) for $360,000. Following the Form 4 filing with the SEC, Meckler has control over a total of 87,500 common shares of the company, with 87,500 shares held directly.
SEC Filing: